Samsung Electronics Makes First Investment of the Year in MedTech, Targeting Future Growth

Samsung Electronics has chosen a U.S. medtech firm as its first investment of 2025, committing approximately 270 billion KRW to Element Biosciences, a genomic sequencing equipment company.